{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:20:53Z","timestamp":1787505653067,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"the Ministry of Science and Education of the Federal Republic of Germany","doi-asserted-by":"publisher","award":["COVIMMUNE\/01KI20343"],"award-info":[{"award-number":["COVIMMUNE\/01KI20343"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Stiftung H\u00e4motherapie-Forschung (Hemotherapy Research Foundation)","award":["COVIMMUNE\/01KI20343"],"award-info":[{"award-number":["COVIMMUNE\/01KI20343"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Sepsis-associated coagulopathy increases risk of mortality. Impairment of the anticoagulant protein C (PC) pathway may contribute to the thrombotic phenotype in coronavirus disease 2019 (COVID-19) sepsis. This study assessed the functionality of this pathway in COVID-19 and non-COVID sepsis by measuring its key enzymes, thrombin and activated PC (APC). The study population included 30 patients with COVID-19, 47 patients with non-COVID sepsis, and 40 healthy controls. In healthy controls, coagulation activation and subsequent APC formation was induced by 15 \u00b5g\/kg recombinant activated factor VII one hour before blood sampling. APC and thrombin in plasma were measured using oligonucleotide-based enzyme capture assays. The indirect thrombin markers prothrombin-fragment 1+2 (F1+2) and thrombin-antithrombin complex (TAT) were also measured. Compared with stimulated healthy controls, median thrombin, F1+2, and TAT levels were higher in patients with COVID-19 (up to 6-fold, p &lt; 2 \u00d7 10\u22126) and non-COVID sepsis (up to 4.7-fold, p &lt; 0.010). APC levels were 2.4-fold higher in patients with COVID-19 (7.44 pmol\/L, p = 0.011) and 3.4-fold higher in non-COVID sepsis patients (10.45 pmol\/L, p = 2 \u00d7 10\u22124) than in controls (3.08 pmol\/L). Thrombin markers and APC showed correlation in both COVID-19 (r = 0.364\u20130.661) and non-COVID sepsis patients (r = 0.535\u20130.711). After adjustment for PC levels, median APC\/thrombin, APC\/F1+2, and APC\/TAT ratios were 2-fold (p = 0.036), 6-fold (p = 3 \u00d7 10\u22127) and 3-fold (p = 8 \u00d7 10\u22124) lower in the COVID-19 group than in the non-COVID sepsis group, and the latter two were also lower in the COVID-19 group than in stimulated healthy controls. In conclusion, it was found that a comparatively lower anticoagulant APC response in COVID-19 patients as compared to non-COVID sepsis patients, potentially linked to endothelial dysfunction, contributes to the prothrombotic phenotype of COVID-19 sepsis.<\/jats:p>","DOI":"10.3390\/biomedicines12091982","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T06:51:17Z","timestamp":1725259877000},"page":"1982","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decreased Protein C Pathway Activity in COVID-19 Compared to Non-COVID Sepsis: An Observational and Comparative Cohort Study"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-2453","authenticated-orcid":false,"given":"Heiko","family":"R\u00fchl","sequence":"first","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0830-870X","authenticated-orcid":false,"given":"Christian","family":"Bode","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Becher","sequence":"additional","affiliation":[{"name":"First Department of Medicine, University Medical Centre Mannheim, Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Eckert","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaith","family":"Mohsen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5216-6270","authenticated-orcid":false,"given":"Hannah L.","family":"McRae","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7713-9631","authenticated-orcid":false,"given":"Jens","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Reda","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Lo\u00dfnitzer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1585-4100","authenticated-orcid":false,"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Putensen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"P\u00f6tzsch","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s13054-023-04762-6","article-title":"Targeting the host response in sepsis: Current approaches and future evidence","volume":"27","author":"Bode","year":"2023","journal-title":"Crit. Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"009","DOI":"10.1055\/s-0034-1398376","article-title":"Coagulation in Patients with Severe Sepsis","volume":"41","author":"Levi","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","article-title":"COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity","volume":"41","author":"Bouck","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/jth.15327","article-title":"Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study","volume":"19","author":"Juneja","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-2001-18863","article-title":"Disseminated Intravascular Coagulation in Sepsis","volume":"27","author":"Hardaway","year":"2001","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1074\/jbc.274.10.6704","article-title":"Reconstitution of the Human Endothelial Cell Protein C Receptor with Thrombomodulin in Phosphatidylcholine Vesicles Enhances Protein C Activation","volume":"274","author":"Xu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","article-title":"Activated protein C, protease activated receptor 1, and neuroprotection","volume":"132","author":"Griffin","year":"2018","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","article-title":"Understanding COVID-19-associated coagulopathy","volume":"22","author":"Conway","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thromres.2021.05.016","article-title":"Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19","volume":"204","author":"Stanne","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e64330","DOI":"10.7554\/eLife.64330","article-title":"SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung","volume":"10","author":"Mast","year":"2021","journal-title":"eLife"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101069","DOI":"10.1016\/j.eclinm.2021.101069","article-title":"Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection","volume":"39","author":"Francischetti","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/MBC.0000000000001070","article-title":"Relationship between serum soluble en-dothelial protein C receptor level and COVID-19 findings","volume":"32","author":"Bayrakci","year":"2021","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Won, T., Wood, M.K., Hughes, D.M., Talor, M.V., Ma, Z., Schneider, J., Skinner, J.T., Asady, B., Goerlich, E., and Halushka, M.K. (2022). Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine, 75.","DOI":"10.1016\/j.ebiom.2022.103812"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcrc.2018.06.003","article-title":"The evolution of activated protein C plasma levels in septic shock and its association with mortality: A prospective observational study","volume":"47","author":"Becher","year":"2018","journal-title":"J. Crit. Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11239-019-01992-w","article-title":"Characterization of circulating thrombin in patients with septic shock: A prospective observational study","volume":"50","author":"Becher","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_19","first-page":"100151","article-title":"Different spreading dynamics througout Germany during the second wave of the COVID-19 pandemic: A time series study based on national surveillance data","volume":"6","author":"Schuppert","year":"2021","journal-title":"Lancet Reg. Health\u2013Eur."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1002\/anie.201007032","article-title":"Profiling of Active Thrombin in Human Blood by Supramolecular Complexes","volume":"50","author":"Becher","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1538-7836.2012.04623.x","article-title":"Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay","volume":"10","author":"Friedrich","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Billoir, P., Lepr\u00eatre, P., Thill, C., Bellien, J., Duchez, V.L.C., Selim, J., Tamion, F., Clavier, T., and Besnier, E. (2022). Routine and Advanced Laboratory Tests for Hemostasis Disorders in COVID-19 Patients: A Prospective Cohort Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051383"},{"key":"ref_24","first-page":"031","article-title":"Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding\u2014A Systematic Review and a Cohort Study","volume":"48","author":"Hvas","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.119.315037","article-title":"Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers","volume":"125","author":"Berens","year":"2019","journal-title":"Circ. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/blood.2021012250","article-title":"Vasculopathy in COVID-19","volume":"140","author":"Flaumenhaft","year":"2022","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3904\/kjim.2020.336","article-title":"MicroCLOTS pathophysiology in coronavirus disease 2019","volume":"38","author":"Renzi","year":"2020","journal-title":"Korean J. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Meini, S., Zanichelli, A., Sbrojavacca, R., Iuri, F., Roberts, A.T., Suffritti, C., and Tascini, C. (2020). Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02014"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ajpath.2021.05.007","article-title":"COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mecahnism of Endothelial Injury","volume":"191","author":"Nicosia","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jtha.2024.02.013","article-title":"Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: What have we learned?","volume":"22","author":"Iba","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1097\/CCM.0000000000005441","article-title":"Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation: Differences Between COVID-19 and Other Viral Acute Respiratory Distress Syndrome","volume":"50","author":"Seeliger","year":"2022","journal-title":"Crit. Care Med."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/9\/1982\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:46:57Z","timestamp":1760111217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/9\/1982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["biomedicines12091982"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12091982","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]}}}